These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 14592942)

  • 1. Novel anti-inflammatory actions of amlodipine in a rat model of arteriosclerosis induced by long-term inhibition of nitric oxide synthesis.
    Kataoka C; Egashira K; Ishibashi M; Inoue S; Ni W; Hiasa K; Kitamoto S; Usui M; Takeshita A
    Am J Physiol Heart Circ Physiol; 2004 Feb; 286(2):H768-74. PubMed ID: 14592942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calcium channel blockades exhibit anti-inflammatory and antioxidative effects by augmentation of endothelial nitric oxide synthase and the inhibition of angiotensin converting enzyme in the N(G)-nitro-L-arginine methyl ester-induced hypertensive rat aorta: vasoprotective effects beyond the blood pressure-lowering effects of amlodipine and manidipine.
    Toba H; Nakagawa Y; Miki S; Shimizu T; Yoshimura A; Inoue R; Asayama J; Kobara M; Nakata T
    Hypertens Res; 2005 Aug; 28(8):689-700. PubMed ID: 16392774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiinflammatory and antiarteriosclerotic effects of pioglitazone.
    Ishibashi M; Egashira K; Hiasa K; Inoue S; Ni W; Zhao Q; Usui M; Kitamoto S; Ichiki T; Takeshita A
    Hypertension; 2002 Nov; 40(5):687-93. PubMed ID: 12411463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiinflammatory and antiarteriosclerotic actions of HMG-CoA reductase inhibitors in a rat model of chronic inhibition of nitric oxide synthesis.
    Ni W; Egashira K; Kataoka C; Kitamoto S; Koyanagi M; Inoue S; Takeshita A
    Circ Res; 2001 Aug; 89(5):415-21. PubMed ID: 11532902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular endothelial growth factor is necessary in the development of arteriosclerosis by recruiting/activating monocytes in a rat model of long-term inhibition of nitric oxide synthesis.
    Zhao Q; Egashira K; Inoue S; Usui M; Kitamoto S; Ni W; Ishibashi M; Hiasa Ki K; Ichiki T; Shibuya M; Takeshita A
    Circulation; 2002 Mar; 105(9):1110-5. PubMed ID: 11877364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Important role of Rho-kinase in the pathogenesis of cardiovascular inflammation and remodeling induced by long-term blockade of nitric oxide synthesis in rats.
    Kataoka C; Egashira K; Inoue S; Takemoto M; Ni W; Koyanagi M; Kitamoto S; Usui M; Kaibuchi K; Shimokawa H; Takeshita A
    Hypertension; 2002 Feb; 39(2):245-50. PubMed ID: 11847192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of monocyte chemoattractant protein-1 in cardiovascular remodeling induced by chronic blockade of nitric oxide synthesis.
    Koyanagi M; Egashira K; Kitamoto S; Ni W; Shimokawa H; Takeya M; Yoshimura T; Takeshita A
    Circulation; 2000 Oct; 102(18):2243-8. PubMed ID: 11056100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term treatment with N(omega)-nitro-L-arginine methyl ester causes arteriosclerotic coronary lesions in endothelial nitric oxide synthase-deficient mice.
    Suda O; Tsutsui M; Morishita T; Tanimoto A; Horiuchi M; Tasaki H; Huang PL; Sasaguri Y; Yanagihara N; Nakashima Y
    Circulation; 2002 Sep; 106(13):1729-35. PubMed ID: 12270870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade: effects on cardiovascular remodeling in rats induced by the long-term blockade of nitric oxide synthesis.
    Takemoto M; Egashira K; Tomita H; Usui M; Okamoto H; Kitabatake A; Shimokawa H; Sueishi K; Takeshita A
    Hypertension; 1997 Dec; 30(6):1621-7. PubMed ID: 9403592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Important role of local angiotensin II activity mediated via type 1 receptor in the pathogenesis of cardiovascular inflammatory changes induced by chronic blockade of nitric oxide synthesis in rats.
    Usui M; Egashira K; Tomita H; Koyanagi M; Katoh M; Shimokawa H; Takeya M; Yoshimura T; Matsushima K; Takeshita A
    Circulation; 2000 Jan; 101(3):305-10. PubMed ID: 10645927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regression by ACE inhibition of arteriosclerotic changes induced by chronic blockade of NO synthesis in rats.
    Katoh M; Egashira K; Kataoka C; Usui M; Koyanagi M; Kitamoto S; Ohmachi Y; Takeshita A; Narita H
    Am J Physiol Heart Circ Physiol; 2001 May; 280(5):H2306-12. PubMed ID: 11299235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathogenic role of oxidative stress in vascular angiotensin-converting enzyme activation in long-term blockade of nitric oxide synthesis in rats.
    Usui M; Egashira K; Kitamoto S; Koyanagi M; Katoh M; Kataoka C; Shimokawa H; Takeshita A
    Hypertension; 1999 Oct; 34(4 Pt 1):546-51. PubMed ID: 10523324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin-converting enzyme inhibition and angiotensin AT1-receptor antagonism equally improve endothelial vasodilator function in L-NAME-induced hypertensive rats.
    De Gennaro Colonna V; Rigamonti A; Fioretti S; Bonomo S; Manfredi B; Ferrario P; Bianchi M; Berti F; Muller EE; Rossoni G
    Eur J Pharmacol; 2005 Jun; 516(3):253-9. PubMed ID: 15963975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Important role of tissue angiotensin-converting enzyme activity in the pathogenesis of coronary vascular and myocardial structural changes induced by long-term blockade of nitric oxide synthesis in rats.
    Takemoto M; Egashira K; Usui M; Numaguchi K; Tomita H; Tsutsui H; Shimokawa H; Sueishi K; Takeshita A
    J Clin Invest; 1997 Jan; 99(2):278-87. PubMed ID: 9005996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term inhibition of nitric oxide synthesis increases arterial thrombogenecity in rat carotid artery.
    Kubo-Inoue M; Egashira K; Usui M; Takemoto M; Ohtani K; Katoh M; Shimokawa H; Takeshita A
    Am J Physiol Heart Circ Physiol; 2002 Apr; 282(4):H1478-84. PubMed ID: 11893585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin-converting enzyme inhibitor prevents plasminogen activator inhibitor-1 expression in a rat model with cardiovascular remodeling induced by chronic inhibition of nitric oxide synthesis.
    Katoh M; Egashira K; Mitsui T; Chishima S; Takeshita A; Narita H
    J Mol Cell Cardiol; 2000 Jan; 32(1):73-83. PubMed ID: 10652192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pravastatin attenuates cardiovascular inflammatory and proliferative changes in a rat model of chronic inhibition of nitric oxide synthesis by its cholesterol-lowering independent actions.
    Egashira K; Ni W; Inoue S; Kataoka C; Kitamoto S; Koyanagi M; Takeshita A
    Hypertens Res; 2000 Jul; 23(4):353-8. PubMed ID: 10912772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-acting Ca2+ blockers prevent myocardial remodeling induced by chronic NO inhibition in rats.
    Sanada S; Node K; Minamino T; Takashima S; Ogai A; Asanuma H; Ogita H; Liao Y; Asakura M; Kim J; Hori M; Kitakaze M
    Hypertension; 2003 Apr; 41(4):963-7. PubMed ID: 12629037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sildenafil augments the beneficial hemodynamic and histopathological effects of amlodipine in nitric oxide-deficient hypertensive rats: role of nitric oxide-cyclic GMP pathway.
    Aboutabl ME; Raafat M; Maklad YA; Kenawy SA; El Din AG
    Pharmacol Res; 2008 Jun; 57(6):456-63. PubMed ID: 18572415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antihypertensive agents prevent nephrosclerosis and left ventricular hypertrophy induced in rats by prolonged inhibition of nitric oxide synthesis.
    Akuzawa N; Nakamura T; Kurashina T; Saito Y; Hoshino J; Sakamoto H; Sumino H; Ono Z; Nagai R
    Am J Hypertens; 1998 Jun; 11(6 Pt 1):697-707. PubMed ID: 9657629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.